Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Association between family history and herpes zoster: a case-control study.

Ansar A, Farshchian M, Ghasemzadeh M, Sobhan MR.

J Res Health Sci. 2014 Spring;14(2):111-4.

2.

Family history as a risk factor for herpes zoster: a case-control study.

Hicks LD, Cook-Norris RH, Mendoza N, Madkan V, Arora A, Tyring SK.

Arch Dermatol. 2008 May;144(5):603-8. doi: 10.1001/archderm.144.5.603.

PMID:
18490586
3.

Family history and herpes zoster risk in the era of shingles vaccination.

Hernandez PO, Javed S, Mendoza N, Lapolla W, Hicks LD, Tyring SK.

J Clin Virol. 2011 Dec;52(4):344-8. doi: 10.1016/j.jcv.2011.08.014. Epub 2011 Sep 15.

PMID:
21924676
4.

No evidence of family history as a risk factor for herpes zoster in patients with post-herpetic neuralgia.

Gatti A, Pica F, Boccia MT, De Antoni F, Sabato AF, Volpi A.

J Med Virol. 2010 May;82(6):1007-11. doi: 10.1002/jmv.21748.

PMID:
20419815
5.

Herpes zoster: family history and psychological stress-case-control study.

Lasserre A, Blaizeau F, Gorwood P, Bloch K, Chauvin P, Liard F, Blanchon T, Hanslik T.

J Clin Virol. 2012 Oct;55(2):153-7. doi: 10.1016/j.jcv.2012.06.020. Epub 2012 Jul 21.

PMID:
22824229
6.

A case control study on family history as a risk factor for herpes zoster and associated outcomes, Beijing, China.

Suo L, Lu L, Li J, Sun M, Wang H, Peng X, Yang F, Pang X, Marin M, Wang C.

BMC Infect Dis. 2017 May 9;17(1):334. doi: 10.1186/s12879-017-2416-7.

9.

Factors associated with herpes zoster vaccination status and acceptance of vaccine recommendation in community pharmacies.

Teeter BS, Garza KB, Stevenson TL, Williamson MA, Zeek ML, Westrick SC.

Vaccine. 2014 Sep 29;32(43):5749-54. doi: 10.1016/j.vaccine.2014.08.040. Epub 2014 Aug 27.

PMID:
25171848
10.

Quantification of risk factors for herpes zoster: population based case-control study.

Forbes HJ, Bhaskaran K, Thomas SL, Smeeth L, Clayton T, Langan SM.

BMJ. 2014 May 13;348:g2911. doi: 10.1136/bmj.g2911.

11.

Contacts with children and young people and adult risk of suffering herpes zoster.

Salleras M, Domínguez A, Soldevila N, Prat A, Garrido P, Torner N, Borrás E, Salleras L.

Vaccine. 2011 Oct 13;29(44):7602-5. doi: 10.1016/j.vaccine.2011.08.023. Epub 2011 Sep 1.

PMID:
21889558
12.

Herpes zoster in immunocompromised patients: incidence, timing, and risk factors.

Wung PK, Holbrook JT, Hoffman GS, Tibbs AK, Specks U, Min YI, Merkel PA, Spiera R, Davis JC, St Clair EW, McCune J, Ytterberg SR, Allen NB, Stone JH; WGET Research Group.

Am J Med. 2005 Dec;118(12):1416.

PMID:
16378799
13.

Community and patient values for preventing herpes zoster.

Lieu TA, Ortega-Sanchez I, Ray GT, Rusinak D, Yih WK, Choo PW, Shui I, Kleinman K, Harpaz R, Prosser LA.

Pharmacoeconomics. 2008;26(3):235-49.

PMID:
18282017
14.

Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster.

Mills R, Tyring SK, Levin MJ, Parrino J, Li X, Coll KE, Stek JE, Schlienger K, Chan IS, Silber JL.

Vaccine. 2010 Jun 7;28(25):4204-9. doi: 10.1016/j.vaccine.2010.04.003. Epub 2010 Apr 21.

PMID:
20416263
15.

Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.

Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, Levin MJ, McElhaney JE, Poder A, Puig-Barberà J, Vesikari T, Watanabe D, Weckx L, Zahaf T, Heineman TC; ZOE-50 Study Group.

N Engl J Med. 2015 May 28;372(22):2087-96. doi: 10.1056/NEJMoa1501184. Epub 2015 Apr 28.

16.

Herpes zoster vaccine and the incidence of recurrent herpes zoster in an immunocompetent elderly population.

Tseng HF, Chi M, Smith N, Marcy SM, Sy LS, Jacobsen SJ.

J Infect Dis. 2012 Jul 15;206(2):190-6. doi: 10.1093/infdis/jis334. Epub 2012 Jun 4.

PMID:
22669900
17.

Live, attenuated varicella zoster vaccination of an immunocompromised patient.

Curtis KK, Connolly MK, Northfelt DW.

J Gen Intern Med. 2008 May;23(5):648-9. doi: 10.1007/s11606-008-0558-4. Epub 2008 Feb 20.

18.

Varicella zoster virus-specific immune responses to a herpes zoster vaccine in elderly recipients with major depression and the impact of antidepressant medications.

Irwin MR, Levin MJ, Laudenslager ML, Olmstead R, Lucko A, Lang N, Carrillo C, Stanley HA, Caulfield MJ, Weinberg A, Chan IS, Clair J, Smith JG, Marchese RD, Williams HM, Beck DJ, McCook PT, Zhang JH, Johnson G, Oxman MN.

Clin Infect Dis. 2013 Apr;56(8):1085-93. doi: 10.1093/cid/cis1208. Epub 2013 Feb 13.

19.

Risk of herpes zoster in CKD: a matched-cohort study based on administrative data.

Wu MY, Hsu YH, Su CL, Lin YF, Lin HW.

Am J Kidney Dis. 2012 Oct;60(4):548-52. doi: 10.1053/j.ajkd.2012.03.018. Epub 2012 May 9.

PMID:
22575666
20.

Risk of herpes zoster in patients with systemic lupus erythematosus: a three-year follow-up study using a nationwide population-based cohort.

Chen HH, Chen YM, Chen TJ, Lan JL, Lin CH, Chen DY.

Clinics (Sao Paulo). 2011;66(7):1177-82. Erratum in: Clinics (Sao Paulo). 2012 Sep;67(9):1123.

Supplemental Content

Support Center